Wolfspeed Q4 FY26 GAAP net loss narrows to USD 145.4 million; revenue drops to USD 149.6 million

Reuters2026/08/19 20:07

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Wolfspeed posted Q4 fiscal 2026 revenue of USD 149.6 million, down 24.06% year-over-year, with GAAP net loss of USD 145.4 million.
GAAP gross margin was negative 25%, worsening 12 percentage points year-over-year; non-GAAP gross margin was negative 20%.
Adjusted EBITDA (non-GAAP) widened to negative USD 62.4 million; operating cash flow was negative USD 54.1 million.
Cash, cash equivalents and short-term investments totaled USD 1.1 billion at June 28, 2026; $46 million of convertible notes converted to equity.
Q1 fiscal 2027 revenue forecast at USD 140 million to USD 160 million; non-GAAP gross margin expected to remain negative.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wolfspeed Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260819859398) on August 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经•2026/09/14 00:46

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260

Reuters•2026/09/14 00:39

Oman postpones the meeting originally scheduled for the 14th with Iran and other countries; the US warns: Don't expect a breakthrough in the Strait of Hormuz

华尔街见闻•2026/09/14 00:23